The company’s valuation, which surged past $40 billion this year, fell by almost a fifth on a dimmer outlook for its closely ...
The results position Takeda, which acquired its therapy in one of the industry’s larger single-drug acquisitions, to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback